Company / FCF Margin
Gossamer Bio, Inc. FCF Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-353.5%
FY2025
5-year range
-353.5% / -3.0%
FY2024-FY2025
Trend
-11605.3%
vs FY2024
Sector context
#107 of 134
Health Care
What the data says
Gossamer Bio, Inc.'s fcf margin of -353.5% is lower than 80% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-353.5% in FY2025.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 134This company -353.5% Sector average -637.8%
▼
+44.6% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 11605.3% year-over-year.
- Currently 284.3pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -353.5% | -11605.3% |
| FY2024 | -3.0% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026